InvestingPro analysis suggests the stock is currently undervalued relative to its Fair Value. Centene's recent divestiture of approximately 11 non-core assets and the offloading of its pharmacy ...

We recently published a list of Top 9 Healthcare Stocks to Buy According to Billionaire David Einhorn. In this article, we ...

With a market capitalization of nearly $31 billion and trading at an attractive P/E ratio of 9.9x, InvestingPro analysis suggests the stock is currently undervalued relative to its Fair Value. Centene ...

Centene's business transformation ... relationship with any company whose stock is mentioned in this article. Seeking Alpha's Disclosure: Past performance is no guarantee of future results.

Reviewing a company’s long-term sales performance ... new contracts. Centene has huge potential even though it has some open questions. After the recent drawdown, the stock trades at 8.5× ...

including Centene (NYSE:CNC) and its peers. Let’s dig into the relative performance of Cigna (NYSE:CI) and its peers as we unravel the now-completed Q4 health insurance providers earnings season.